cord blood-derived NK cell therapy (Third Affiliated Hospital of Kunming Medical University)

N/A

Report date: 2025/01/26 19:23:36

Base Information

Drug Namecord blood-derived NK cell therapy (Third Affiliated Hospital of Kunming Medical University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionImmunostimulantsNatural killer cells stimulants
TargetsUpdating
Therapy Area/IndicationsColorectal NeoplasmsAdenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesThe Third Affiliated Hospital of Kunming Medical University
China Registration ClassN/A

Develop Information

Active CompaniesThe Third Affiliated Hospital of Kunming Medical University
Inactive CompaniesN/A
Active IndicationsColorectal NeoplasmsAdenocarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A